Concepedia

Ronald Farquhar

RF

Statistics

Publications

5

Citations

178

H-Index

5

Active since

2006

Affiliations

Io Therapeutics (United States)(Current)

Ronald Farquhar is an author at Io Therapeutics (United States) specializing in antibiotic resistance, infectious diseases, and life sciences.

Publications per year

2006–2023

5

Publications

5

Antibiotic research and development: business as usual?

Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett et al. · Journal of Antimicrobial Chemotherapy · 2015 · 83 citations · Full text

, , +12

A novel dual <scp>NLRP1</scp> and <scp>NLRP3</scp> inflammasome inhibitor for the treatment of inflammatory diseases

Callum AH Docherty, Anuruddika J Fernando, Sarah Rosli et al. · Clinical & Translational Immunology · 2023 · 39 citations · Full text

, , +17

Identification of ADS024, a newly characterized strain of Bacillus velezensis with direct Clostridiodes difficile killing and toxin degradation bio-activities

Michelle O’Donnell, James W. Hegarty, Brian C. Healy et al. · Scientific Reports · 2022 · 26 citations · Full text

, , +14

Efficacy of Novel Rifamycin Derivatives against Rifamycin-Sensitive and -Resistant <i>Staphylococcus aureus</i> Isolates in Murine Models of Infection

David M. Rothstein, Ronald Farquhar, Klari Sirokman et al. · Antimicrobial Agents and Chemotherapy · 2006 · 19 citations · Full text

, , +10

Development of ADS051, an oral, gut‐restricted, small molecule neutrophil modulator for the treatment of neutrophil‐mediated inflammatory diseases

Christopher K. Murphy, Bharat L. Dixit, Frederick B. Oleson et al. · FEBS Open Bio · 2023 · 11 citations · Full text

, , +17

1–5 of 5